Feedback / Questions
CP-383 - Tasca Therapeutics
https://www.businesswire.com/news/home/20250916066302/en/Tasca-Therapeutics-Doses-First-Patient-in-Phase-12-Dose-Escalation-and-Expansion-Trial-Evaluating-CP-383-in-Advanced-Solid-Tumors
Sep 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next